These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 6081483)
41. Some characteristics of lysogens of Mycobacterium smegmatis. Háber KJ; Földes I Acta Microbiol Hung; 1984; 31(2):135-40. PubMed ID: 6464659 [TBL] [Abstract][Full Text] [Related]
42. [Detection of mycobacteriophages in tuberculosis and sarcoidosis patients]. Koz'min-Sokolov BN; Kostina ZI Probl Tuberk; 1971; 49(12):74-5. PubMed ID: 5159694 [No Abstract] [Full Text] [Related]
43. ["Danger theory" as a common mechanism of sarcoidosis induction by infectious and non-infectious factors - a role of genetics factors]. Dubaniewicz A Pol Merkur Lekarski; 2018 Mar; 44(261):91-96. PubMed ID: 29601555 [TBL] [Abstract][Full Text] [Related]
45. LYSOGENY IN THE MYCOBACTERIA. II. SOME PHAGE-HOST RELATIONSHIPS OF LYSOGENIC MYCOBACTERIA. RUSSELL RL; JANN GJ; FROMAN S Am Rev Respir Dis; 1963 Oct; 88():528-38. PubMed ID: 14068438 [No Abstract] [Full Text] [Related]
46. Mycobacteria and sarcoidosis: an overview and summary of recent molecular biological data. Mangiapan G; Hance AJ Sarcoidosis; 1995 Mar; 12(1):20-37. PubMed ID: 7617973 [No Abstract] [Full Text] [Related]
47. Host modification and restriction with a mycobacteriophage isolated from a pseudolysogenic Mycobacterium chelonei. Jones WD; Greenberg J J Gen Microbiol; 1977 Apr; 99(2):389-95. PubMed ID: 874454 [TBL] [Abstract][Full Text] [Related]
48. Diagnostic procedures in sarcoidosis. Mankiewicz E; Kurti V; Béland J Can Med Assoc J; 1971 Apr; 104(8):684-90. PubMed ID: 5550375 [TBL] [Abstract][Full Text] [Related]
49. Microbial antigen treatment in sarcoidosis--a new paradigm? Tercelj M; Salobir B; Rylander R Med Hypotheses; 2008; 70(4):831-4. PubMed ID: 17850985 [TBL] [Abstract][Full Text] [Related]
50. [Examination of the bronchoalveolar lavage fluid and blood plasma of patients with sarcoidosis]. Khomenko AG; Golyshevskaia VI; El'shanskaia MP Klin Med (Mosk); 1987 Dec; 65(12):80-4. PubMed ID: 3444317 [No Abstract] [Full Text] [Related]
51. Further exploratory studies in sarcoidosis. An epidemiologic investigation to compare the prevalence of tuberculosis infection and-or disease among contacts of matched sarcoidosis and asthmatic patients. Zaki MH; Addrizzo JR; Patton JM; Murphy JJ Am Rev Respir Dis; 1971 Apr; 103(4):539-45. PubMed ID: 4994460 [No Abstract] [Full Text] [Related]
53. Further evidence against the concept of decreased phage neutralizing ability of serum of patients with sarcoidosis. Bowman BU; Daniel TM Am Rev Respir Dis; 1971 Dec; 104(6):908-14. PubMed ID: 5125591 [No Abstract] [Full Text] [Related]
54. [Advances in microbiological diagnosis of tuberculosis and sarcoidosis]. Safonova SG; Golyshevskaia VI; Gedymin LE; Chernousova LN Probl Tuberk; 1996; (6):75-8. PubMed ID: 9019780 [TBL] [Abstract][Full Text] [Related]
55. Identification of expression signals of the mycobacteriophages Bxb1, L1 and TM4 using the Escherichia-Mycobacterium shuttle plasmids pYUB75 and pYUB76 designed to create translational fusions to the lacZ gene. Barletta RG; Kim DD; Snapper SB; Bloom BR; Jacobs WR J Gen Microbiol; 1992 Jan; 138(1):23-30. PubMed ID: 1556552 [TBL] [Abstract][Full Text] [Related]
57. Etiologic role of infectious agents. Chen ES; Moller DR Semin Respir Crit Care Med; 2014 Jun; 35(3):285-95. PubMed ID: 25007081 [TBL] [Abstract][Full Text] [Related]
58. [Serological studies in patients with Boeck's disease in relation to the incidence of antibodies against atypical mycobacteria]. Hergt R; Schünemann G Z Gesamte Inn Med; 1970 Apr; 25(8):366-9. PubMed ID: 5002041 [No Abstract] [Full Text] [Related]